Evaluation of Oral Prostaglandin E1 in Management of Ductus Dependent Congenital Heart Disease
Purpose: Intravenous prostaglandin E1 (PGE1) infusion is a treatment which has been proven to be effective in ductus dependent congenital heart disease. However, PGE1 is very expensive, needed continuous infusion and its supply is difficult by every center. When its long term use is necessary, these...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cukurova University
2012-06-01
|
Series: | Çukurova Üniversitesi Tıp Fakültesi Dergisi |
Subjects: | |
Online Access: | http://www.scopemed.org/fulltextpdf.php?mno=20327 |